Eulalia B Villegas Bruguera, Kevin Molina Mata, Magdalena Fernandez Martinez de Mandojana, Iosune Guillén Blanco, Manuel Sánchez Cánovas
{"title":"Hospital at home for oncologic patients: SEOM-SEHAD consensus on clinical practice.","authors":"Eulalia B Villegas Bruguera, Kevin Molina Mata, Magdalena Fernandez Martinez de Mandojana, Iosune Guillén Blanco, Manuel Sánchez Cánovas","doi":"10.1007/s12094-025-03875-4","DOIUrl":null,"url":null,"abstract":"<p><p>The number of oncologic patients and survival rates are increasing worldwide. This fact implies greater comorbidity and complications associated with cancer and oncologic therapies. Many of these complications require hospitalization which constitutes an additional risk factor for the patient, due to the nosocomial burden such as infections, severe functional deficits or depression. Moreover, the increasing number of hospitalizations implies a significant increase in global sanitary costs. Hospital at Home (HaH) is a resource that allows decompensated patient to remain in home, attended and treated by a hospital multidisciplinary team. Furthermore, HaH has been shown to be clearly cost-effective in multiple pathologies compared to conventional hospitalization. A group of experts from the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Hospital at Home (SEHAD) met to discuss a brief update on home complex attention of oncologic patients and agree on aspects relating to the clinical diagnosis, admission criteria and management of different profiles.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"3860-3866"},"PeriodicalIF":2.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460374/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03875-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The number of oncologic patients and survival rates are increasing worldwide. This fact implies greater comorbidity and complications associated with cancer and oncologic therapies. Many of these complications require hospitalization which constitutes an additional risk factor for the patient, due to the nosocomial burden such as infections, severe functional deficits or depression. Moreover, the increasing number of hospitalizations implies a significant increase in global sanitary costs. Hospital at Home (HaH) is a resource that allows decompensated patient to remain in home, attended and treated by a hospital multidisciplinary team. Furthermore, HaH has been shown to be clearly cost-effective in multiple pathologies compared to conventional hospitalization. A group of experts from the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Hospital at Home (SEHAD) met to discuss a brief update on home complex attention of oncologic patients and agree on aspects relating to the clinical diagnosis, admission criteria and management of different profiles.
期刊介绍:
Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.